LA JOLLA, Calif.--(BUSINESS WIRE)--Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced the appointment of Mary Glanville as senior vice president of human capital and Christopher Aker as senior director of legal affairs and secretary.
